Cardiovascular Drug Therapy for Human Newborn: Review of Pharmacodynamic Data

Creative Commons License

Ergenekon E., Rojas-Anaya H., Bravo M. C., Kotidis C., Mahoney L., Rabe H.

CURRENT PHARMACEUTICAL DESIGN, cilt.23, sa.38, ss.5850-5860, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 23 Sayı: 38
  • Basım Tarihi: 2017
  • Doi Numarası: 10.2174/1381612823666170918122755
  • Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.5850-5860
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Circulatory failure in preterm and term newborn infants is commonly treated with inotropes or vasoactive medications. In this structured literature review, the available data on pharmacodynamic effects of the inotropes adrenaline, dobutamine, dopamine, levosimendan, milrinone, noradrenaline, and the vasoactive drugs vasopressin and hydrocortisone are presented.